Sara Buhrlage

Sara Buhrlage, PhD is an Associate Professor in the Dana-Farber Cancer Institute department of Cancer Biology and the Harvard Medical School department of Biological Chemistry and Molecular Pharmacology. Dr. Buhrlage is a leader in harnessing deubiquitylases (DUBs) as emergent drug targets, where her lab has pioneered new approaches for interrogating DUB function, new insights into the chemical tractability of DUBs, and mapping the therapeutic potential of DUBs in cancer. Dr. Buhrlage earned a Doctor of Philosophy in organic chemistry from the University of Michigan and completed a post-doctoral fellowship at the Broad Institute.